natgillin/translations-raw huggingface dataset:
If serum phosphate is confirmed to be < 3.0 mg/dl (0.96 mmol/l) in any paediatric patient receiving tenofovir disoproxil fumarate, renal function should be re-evaluated within one week, including measurements of blood glucose, blood potassium and urine glucose concentrations (see section 4.8, proximal tubulopathy).
Če je pri katerem koli pediatričnem bolniku, ki prejema dizoproksiltenofovirijev fumarat, potrjena koncentracija serumskega fosfata < 3, 0 mg/dl (0,96 mmol/l), je treba ponovno ovrednotiti ledvično funkcijo v roku enega tedna, vključno z merjenjem koncentracije glukoze in kalija v krvi ter glukoze v urinu (glejte poglavje 4.8, proksimalna tubulopatija).
If serum phosphate is confirmed to be < 3.0 mg/dl (0.96 mmol/l) in any paediatric patient receiving tenofovir disoproxil fumarate, renal function should be re-evaluated within one week, including measurements of blood glucose, blood potassium and urine glucose concentrations (see section 4.8, proximal tubulopathy).
Če je pri katerem koli pediatričnem bolniku, ki prejema dizoproksiltenofovirijev fumarat, potrjena koncentracija serumskega fosfata < 3,0 mg/dl (0, 96 mmol/l), je treba ponovno ovrednotiti ledvično funkcijo v roku enega tedna, vključno z merjenjem koncentracije glukoze in kalija v krvi ter glukoze v urinu (glejte poglavje 4.8, proksimalna tubulopatija).
If several Bortezomib Accord doses in a cycle are withheld (≥ 3 doses during twice weekly administration or ≥ 2 doses during weekly administration)
Če preskočite več odmerkov zdravila Bortezomib Accord v enem krogu zdravljenja (≥ 3 odmerke pri odmerjanju dvakrat na teden ali ≥ 2 odmerka pri odmerjanju enkrat na teden)
If several Bortezomib Hospira doses in a cycle are withheld (≥ 3 doses during twice weekly administration or ≥ 2 doses during weekly administration)
Če preskočite več odmerkov zdravila Bortezomib Hospira v enem krogu zdravljenja (≥ 3 odmerke pri odmerjanju dvakrat na teden ali ≥ 2 odmerka pri odmerjanju enkrat na teden)
If several Bortezomib SUN doses in a cycle are withheld (≥ 3 doses during twice weekly administration or ≥ 2 doses during weekly administration)
Če preskočite več odmerkov zdravila Bortezomib SUN v enem krogu zdravljenja (≥ 3 odmerke pri odmerjanju dvakrat na teden ali ≥ 2 odmerka pri odmerjanju enkrat na teden)
If several VELCADE doses in a cycle are withheld (≥ 3 doses during twice weekly administration or ≥ 2 doses during weekly administration)
Če preskočite več odmerkov zdravila VELCADE v enem krogu zdravljenja (≥ 3 odmerke pri odmerjanju dvakrat na
If severe adverse reactions or laboratory abnormalities develop during therapy with ribavirin and interferon alfa-2b, modify the dosages of each product if appropriate, until the adverse reactions abate.
Če se med zdravljenjem z ribavirinom in interferonom alfa-2b pojavijo hudi neželeni učinki ali nenormalni izvidi laboratorijskih preiskav, odmerek vsakega zdravila po potrebi prilagajajte, dokler neželene reakcije ne izginejo.
If severe adverse reactions or laboratory abnormalities develop during treatment with PegIntron monotherapy or combination therapy, the dosages of PegIntron and/or ribavirin must be modified as appropriate, until the adverse reactions abate.
Če se med zdravljenjem z zdravilom PegIntron v monoterapiji ali v kombinirani terapiji pojavijo resni neželeni učinki ali nenormalni laboratorijski izvidi, morate ustrezno prilagoditi odmerke zdravila PegIntron in/ali ribavirina, dokler neželeni učinki ne prenehajo.
If severe adverse reactions or laboratory abnormalities develop during treatment with ViraferonPeg monotherapy or combination therapy, modify the dosages of ViraferonPeg and/or ribavirin as appropriate, until the adverse reactions abate.
Če se med zdravljenjem z zdravilom ViraferonPeg v monoterapiji ali v kombinirani terapiji pojavijo resni neželeni učinki ali nenormalni laboratorijski izvidi, morate ustrezno prilagoditi odmerke zdravila ViraferonPeg in/ali ribavirina, dokler neželeni učinki ne prenehajo.
If severe adverse reactions or laboratory abnormalities develop during treatment with ViraferonPeg monotherapy or combination therapy, the dosages of ViraferonPeg and/or ribavirin must be modified as appropriate, until the adverse reactions abate.
Če se med zdravljenjem z zdravilom ViraferonPeg v monoterapiji ali v kombinirani terapiji pojavijo resni neželeni učinki ali nenormalni laboratorijski izvidi, morate ustrezno prilagoditi odmerke zdravila ViraferonPeg in/ali ribavirina, dokler neželeni učinki ne prenehajo.
If severe diarrhoea (CTCAE grade 3-4) develops, vandetanib should be stopped until diarrhoea improves.
Če se pojavi huda driska (3. - 4. stopnje po CTCAE), je treba zdravljenje z vandetanibom prekiniti, dokler se driska ne izboljša.
If severe diarrhoea recurs on a subsequent cycle, the 5-FU bolus and infusion dose should also be reduced by 20%.
Če se huda driska med naslednjim ciklusom ponovi, je treba bolus 5-FU zmanjšati in odmerek za infundiranje tudi zmanjšati za 20 %.
If severe hypoglycaemia is not treated, it can cause brain damage (temporary or permanent) and even death.
Dolgotrajna nezdravljena huda hipoglikemija lahko povzroči (prehodno ali trajno) okvaro možganov in celo smrt.
If severe infusion reactions occur, immediate discontinuation of the intravenous infusion should be considered.
Če se pojavi huda infuzijska reakcija, preučite možnost takojšnje prekinitve intravenskega infundiranja.
If severe neutropenia (ANC < 500 cells/mm3) lasting more than 5 days or associated with fever or infection occurs, dose reduction is recommended (see section 4.2).
Pri hudi nevtropeniji (ANC < 500 celic/mm3), kit raja več kot 5 dni ali je povezana z zvišano telesno temperature ali okužbo, se priporoča zmanjšanje odmerka (glejte poglavje 4.2).
If severe OHSS occurs, it is recommended that gonadotropin treatment be stopped if still ongoing, and that the patient be hospitalised and appropriate therapy be started.
Če se pojavi hud OHSS, je priporočljivo zdravljenje z gonadotropinom ukiniti, če to še traja, bolnico sprejeti v bolnišnico in začeti ustrezno zdravljenje OHSS.
If severe polycythaemia occurs, conventional methods (phlebotomy) may be indicated to decrease the haemoglobin level.
Če se pojavi huda policitemija, so za zmanjšanje koncentracije hemoglobina lahko indicirani konvencionalni načini (flebotomija).
If severe toxicity occurs, the physician should consider delaying or discontinuing the therapy with the medicinal product until serious complications resolve.
Če se pojavi huda toksičnost, naj zdravnik razmisli o odložitvi ali ukinitivi zdravljenja z zdravilom, dokler resni zapleti niso razrešeni.
If severe, sudden allergic reactions (anaphylactic reactions) occur (very rare), the injection must be stopped immediately.
Če se pojavijo hude, nenadne alergijske (anafilaktične) reakcije (ki so zelo redke), morate injiciranje zdravila nemudoma ustaviti.
If severe, sudden allergic reactions (anaphylactic) occur, the infusion must be stopped immediately.
Če se pojavijo hude, nenadne alergijske (anafilaktične) reakcije, je treba infundiranje nemudoma prekiniti.
If she becomes pregnant or think for any reason that she may be pregnant,
zanosi ali iz kakršnega koli razloga domneva, da bi lahko bila noseča,
If she misses her expected menstrual period,
ji izostane pričakovana menstruacija,
If she stops using contraception unless she commits to not having sexual intercourse (abstinence),
preneha uporabljati kontracepcijo, razen, če se zaveže, da ne bo imela spolnih odnosov (abstinenca),
If side effects develop during the injection/infusion, it may need to be given more slowly or stopped.
Injiciranje/infundiranje bo morda treba upočasniti ali prekiniti, če se med njim pojavijo neželeni učinki.
If side effects impacting tolerability occur, naloxegol should be discontinued.
Če se pojavijo neželeni učinki, ki vplivajo na prenašanje, je treba naloksegol prenehati uporabljati.
If side effects occur, treatment should be discontinued and the advice of a veterinarian should be sought.
Če se pojavijo neželeni učinki, je potrebno zdravljenje prekiniti in se posvetovati z veterinarjem.
If side effects occur, treatment should be discontinued and the advice of a veterinarian should be sought.
Če se pojavijo neželeni učinki, je treba zdravljenje prekiniti in se posvetovati z veterinarjem.
If side effects occur, treatment should be discontinued and the advice of a veterinarian should be sought.
Če se pojavijo neželeni učinki, je treba zdravljenje prekiniti in se posvetovati z zveterinarjem.
If side effects occur, treatment should be discontinued and the advice of a veterinarian should be sought.
Če se pojavijo neželeni učinki, je zdravljenje potrebno prekiniti in se posvetovati z veterinarjem.
If side effects occur, treatment should be discontinued and the advice of a veterinary surgeon should be sought.
V primeru pojava stranskih učinkov prenehajte z zdravljenjem in se posvetujte z veterinarjem.
If side effects occur, treatment should be discontinued and the advice of a veterinary surgeon should be sought.
Če se pojavijo stranski učinki, takoj prenehamo z zdravljenjem.
If side effects occur, treatment should be discontinued.
Če se pojavijo neželeni učinki, moramo zdravljenje prekiniti in se posvetovati z veterinarjem.
If side effects occur, treatment should be discontinued.
Če se pojavijo neželeni učinki, moramo zdravljenje prekiniti.
If signs and symptoms of nephrolithiasis, including flank pain with or without haematuria (including microscopic haematuria) occur, temporary interruption of therapy (e.g. for 1–3 days) during the acute episode of nephrolithiasis or discontinuation of therapy may be considered.
Če se pojavijo znaki in simptomi ledvičnih kamnov, vključno z bolečinami v ledvenem predelu in s hematurijo (vključno z mikrohematurijo) ali brez nje, lahko razmislimo o začasni prekinitvi zdravljenja (npr. za 1–3 dni) med akutnimi napadi zaradi ledvičnih kamnov ali o prenehanju zdravljenja.
If signs and symptoms of tardive dyskinesia appear in a patient on aripiprazole, dose reduction or discontinuation should be considered (see section 4.8).
Če se pri bolniku, ki dobiva aripiprazol, pojavijo znaki in simptomi tardivne diskinezije, je treba razmisliti o zmanjšanju odmerka ali prekinitvi zdravljenja (glejte poglavje 4.8).
If signs and symptoms of tardive dyskinesia appear, the discontinuation of all antipsychotics, including INVEGA, should be considered.
Če se pojavijo znaki in simptomi tardivne diskinezije, po lastni presoji ukinite vse antipsihotike, vključno z zdravilom INVEGA.
If signs and symptoms of tardive dyskinesia appear, the discontinuation of all antipsychotics, including paliperidone, should be considered.
Če se pojavijo znaki in simptomi tardivne diskinezije, je treba pretehtati možnost prekinitve uporabe vseh antipsihotikov, vključno s paliperidonom.
If signs and symptoms resolve rapidly with the above measures, dinutuximab infusion may be resumed at a rate of 0.875 mg/m2/h.
Če znaki in simptomi hitro izginejo po zgornjih ukrepih, se lahko ponovno daje infuzija dinutuksimaba s hitrostjo 0,875 mg/m2/h.
If signs fail to improve within 7 days, treatment should be re-evaluated by the veterinarian
Če po 7 dneh ni nobenih znakov izboljšanja, mora veterinar stanje ponovno oceniti .
if signs of allergy spread to other parts of the body, or if you suddenly feel unwell and you start sweating; start being sick (vomiting); have difficulty in breathing; have a rapid heart beat; feel dizzy; feel like fainting.
e znaki alergije razširijo na druge dele telesa ali se nenadoma slabo pocutite in se zacnete znojiti, vam postane slabo (bruhate), imate težave z dihanjem, vam srce hitro bije, ste omoticni, cutite omedlevico.
If signs of allergy spread to other parts of your body.
če se znaki alergije razširijo na druge dele telesa,
If signs of systemic toxicity appear for example fever, cardiac arrhythmias, shock/hypotension, adult respiratory distress syndrome (ARDS), general supportive measures should be employed and the patient immediately transferred to an Intensive Care Unit for monitoring.
Če se pojavijo znaki sistemske toksičnosti, npr. vročina, srčne aritmije, šok ali hipotenzija ali sindrom dihalne stiske, moramo uvesti splošne podporne ukrepe in bolnika takoj premestiti na oddelek za intenzivno zdravljenje.
If signs or symptoms of hepatic failure are present, sunitinib should be discontinued and appropriate supportive care should be provided.
Če se pojavijo znaki ali simptomi odpovedi jeter, je treba uporabo sunitiniba prekiniti in zagotoviti ustrezno podporno oskrbo.
If signs or symptoms of herpetic infection develop, they should contact their healthcare professional.
Če se jim pojavijo znaki ali simptomi herpetične okužbe, se morajo obrniti na zdravstvenega delavca.
If signs or symptoms of hypersensitivity develop, eslicarbazepine acetate must be discontinued.
Če se pojavijo znaki ali simptomi preobčutljivosti, je treba zdravljenje z eslikarbazepinacetatom prekiniti.
If signs or symptoms of SJS, TEN, or EM (e.g. progressive skin rash often with blisters or mucosal lesions) are present, sunitinib treatment should be discontinued.
Če so prisotni znaki SJS, TEN ali EM (npr. napredujoč kožni izpuščaj, pogosto z mehurji ali lezijami na sluznicah), je treba zdravljenje s sunitinibom prekiniti.
If signs or symptoms of spinal haematoma are suspected, urgent diagnosis and treatment including spinal cord decompression should be initiated.
Če obstaja sum na znake ali simptome spinalnega hematoma, je treba uvesti nujno diagnostiko in zdravljenje, vključno z dekompresijo hrbtenjače.
If signs suggesting allergic reactions occur, in particular, angioedema (including difficulties in breathing or swallowing, swelling of the tongue, lips, and face), urticaria or skin rash, Enurev Breezhaler should be discontinued immediately and alternative therapy instituted.
Če se pojavijo znaki, ki kažejo na alergijsko reakcijo, zlasti angioedem (vključno z oteženim dihanjem ali požiranjem, otekanjem jezika, ustnic in obraza), urtikarija ali izpuščaj, je treba zdravljenje z zdravilom Enurev Breezhaler takoj ukiniti in uvesti drugo zdravilo.
If signs suggesting allergic reactions occur, in particular, angioedema (including difficulties in breathing or swallowing, swelling of the tongue, lips, and face), urticaria or skin rash, Seebri Breezhaler should be discontinued immediately and alternative therapy instituted.
Če se pojavijo znaki, ki kažejo na alergijsko reakcijo, zlasti angioedem (vključno z oteženim dihanjem ali požiranjem, otekanjem jezika, ustnic in obraza), urtikarija ali izpuščaj, je treba zdravljenje z zdravilom Seebri Breezhaler takoj ukiniti in uvesti drugo zdravilo.
If signs suggesting allergic reactions occur, in particular, angioedema (including difficulties in breathing or swallowing, swelling of the tongue, lips, and face), urticaria or skin rash, Tovanor Breezhaler should be discontinued immediately and alternative therapy instituted.
Če se pojavijo znaki, ki kažejo na alergijsko reakcijo, zlasti angioedem (vključno z oteženim dihanjem ali požiranjem, otekanjem jezika, ustnic in obraza), urtikarija ali izpuščaj, je treba zdravljenje z zdravilom Tovanor Breezhaler takoj ukiniti in uvesti drugo zdravilo.
If SJS or any other severe skin reaction is suspected, EXJADE should be discontinued immediately and should not be reintroduced.
V primeru suma na Stevens-Johnsonov sindrom ali drugo resno kožno reakcijo, je treba zdravilo EXJADE bolniku takoj ukiniti, ponovno pa se mu ga ne sme več predpisati.
If skin exposure occurs, wash the affected area immediately with clean water.
Če pride do stika zdravila s kožo, takoj umijte s čisto vodo.
If skin or eye irritation persists, or if the veterinary medicinal product is accidentally swallowed, seek medical advice immediately and show the package leaflet or the label to the physician.
Če je draženje kože ali oči prisotno dalj časa ali pride do nenamernega zaužitja, se takoj posvetujte z zdravnikom in mu pokažite navodila za uporabo ali ovojnino.
If skin or eye irritation persists, or if the veterinary medicine is accidentally swallowed, immediate medical advice should be sought and the package leaflet or label shown to the doctor.
Če draženje kože ali očesa ne preneha ali če pride do nenamernega zaužitja zdravila za uporabo v veterinarski medicini, se morate takoj posvetovati z zdravnikom in mu pokazati navodilo za uporabo ali ovojnino.
If skin or eye irritation persists, or if the veterinary medicine is accidentally swallowed, immediate medical advice should be sought and the package leaflet or label shown to the doctor.
Če draženje kože ali oči ne preneha ali če je prišlo do nenamernega zaužitja zdravila, je treba takoj poiskati zdravniško pomoč in zdravniku pokazati navodilo za uporabo ali nalepko.
If skin or eye irritation persists, or if the veterinary medicine is accidentally swallowed, seek medical advice immediately and show the package leaflet or the label to the physician.
Če je draženje kože ali oči prisotno dalj časa ali pride do nenamernega zaužitja, se takoj posvetujte z zdravnikom in mu pokažite navodila za uporabo ali ovojnino.
If skin or eye symptoms persist, or the product is accidentally swallowed, seek medical advice immediately and show the package leaflet or label to the physician.
V primeru nenamernega zaužitjazdravila ali, če vzdraženje kože ali oči traja, se takoj posvetujte z zdravnikom in mu pokažite navodilo za uporabo ali ovojnino.
If skin or eye symptoms persist, or the product is accidentally swallowed, seek medical advice immediately and show the package leaflet or label to the physician.
V primeru nenamernega zaužitju zdravila ali, če vzdraženje kože ali oči traja, se takoj posvetujte z zravnikom in mu pokažite navodilo za uporabo ali ovojnino.
If skin or eye symptoms persist, or the product is accidentally swallowed, seek medical advice immediately and show the package leaflet or the label to the physician.
V primeru nenamernega zaužitju zdravila ali, če vzdraženje kože ali oči traja, se takoj posvetujte z zravnikom in mu pokažite navodilo za uporabo ali ovojnino.
If skin or if eye irritation persists, or in case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.
Če je draženje kože ali oči prisotno dalj časa ali če pride do nenamernega zaužitja, se takoj posvetujte z zdravnikom in mu pokažite navodilo za uporabo ali ovojnino.
If so, contact your child’s doctor or pharmacist to ask for advice.
Če jih bo dobil, se obrnite za nasvet na otrokovega zdravnika ali farmacevta.
If so, contact your doctor or pharmacist to ask for advice.
Če jih boste dobili, se obrnite za nasvet na svojega zdravnika ali farmacevta.
If so, please indicate type and when last taken
Če da, prosimo navedite katere in
If so, please indicate when treatment ended
Če da, prosimo navedite datum zadnjega dne zdravljenja
If so, your dose may need adjustment
V tem primeru bo morda potrebno prilagoditi odmerek;
If sodium chloride 9 mg/ml (0.9%) solution for infusion is used for infusion, a 0.20 or 0.22 micron in-line polyethersulfone (PES) filter is required.
Če je za infundiranje uporabljena 0,9-% (9 mg/ml) raztopina natrijevega klorida za infundiranje, je treba uporabiti 0,20- ali 0,22-mikronski polietersulfonski (PES) filter v liniji.
If sodium correction exceeds 6 mmol/l during the first 6 hours of administration or 8 mmol/l during the first 6-12 hours, respectively, the possibility that serum sodium correction may be overly rapid should be considered.
Če popravek natrija preseže 6 mmol/l v prvih 6 urah dajanja ali 8 mmol/l v prvih 6 – 12 urah, je treba razmisliti o možnosti prehitrega popravka natrija v serumu.
If sofosbuvir is used in combination with peginterferon alfa, and a patient has a serious adverse reaction potentially related to this drug, the peginterferon alfa dose should be reduced or discontinued.
Če se sofosbuvir uporablja v kombinaciji s peginterferonom alfa in ima bolnik resne neželene učinke, ki so morebiti povezani s tem zdravilom, je treba odmerek peginterferona alfa zmanjšati ali ukiniti.
If SoloStar is in cool storage, it should be taken out 1 to 2 hours before injection to allow it to warm up.
Če je SoloStar shranjen na hladnem, naj ga bolnik vzame iz hladilnika 1 do 2 uri pred injiciranjem, da se ogreje.
If SoloStar is in cool storage, it should be taken out 1 to 2 hours before you inject to allow it to warm up.
Če je SoloStar shranjen na hladnem, naj ga bolnik vzame iz hladilnika 1 do 2 uri pred injiciranjem, da se ogreje.
If some granules are left in the glass, add some more juice and drink straight away.
Če nekaj zrnc ostane v kozarcu, dodajte še malo soka in takoj popijte.
If some medicine accidentally gets into your eyes or your partner’s eyes, rinse them immediately with cold water or saline solution and cover them gently until any effects, such as numbness, wear off.
Če nekaj zdravila po nesreči pride v stik z vašimi očmi ali očmi vaše partnerke, jih takoj izperite s hladno vodo ali fiziološko raztopino in jih nežno prekrijte, dokler učinki, na primer omrtvelost, ne izginejo.
If someone else is giving you the injection, they can also use the outer area of the upper arms
Če vam injekcijo da kdo drug, lahko zdravilo injicira tudi v zunanji del nadlaktov.
If someone else is injecting you, they can also use the back of your arms (see picture 4)
Če vam daje injekcijo kdo drug, vam jo lahko da tudi v zadnji del nadlakti (glejte sliko 4).
If someone has accidentally taken Effentora, they may have the same side effects as described in the section 3 “If you use more Effentora than you should”.
Če je nekdo po nezgodi uporabil zdravilo Effentora, lahko izkusi enake neželene učinke, kot so opisani v poglavju 3 "Če ste uporabili večji odmerek zdravila Effentora, kot bi smeli”.
If someone is accidentally injected with this product, they must seek immediate medical advice even if only a very small amount is injected.
Če je bil nekomu nenamerno vbrizgan ta izdelek, je treba takoj poiskati zdravniški nasvet, tudi če je bila injicirana le zelo majhna količina.
If someone is accidentally injected with this product, they must seek medical advice immediately even if only a very small amount is injected.
V primeru nenamernega injiciranja se je treba nemudoma posvetovati z zdravnikom, tudi če je bila injicirana le zelo majhna količina.
If someone is accidentally injected with this product, they must seek medical attention immediately even if only a very small amount is injected.
V primeru nenamernega injiciranja cepiva je treba nemudoma poiskati zdravniško pomoč, čeprav je bila morda injicirana zelo majhna količina.
If someone swallows or accidentally injects themselves with the medicine, the advice of a doctor should be sought immediately.
Če se zdravilo pogoltne ali nenamerno injicira, se je treba takoj posvetovati z zdravnikom.
If someone will assist in giving you the injection, then he or she may also choose the upper arms as an injection site
Če vam bo kdo drug dal injekcijo, lahko za injekcijsko mesto izbere tudi nadlaket.
If someone will assist in giving you the injection, then he or she may also choose the upper arms as an injection site.
Če vam bo kdo drug dal injekcijo, lahko za injekcijsko mesto izbere tudi nadlaket.
If statin treatment is required during the treatment period, a switch to dose
Če je med obdobjem zdravljenja potrebno
If still no insulin comes out, change the needle, as it might be blocked and try again.
Če insulin še vedno ne pride ven, naj zamenja iglo, saj je morda zamašena in poskusi znova.
If still no insulin comes out, change the needle, as it might be blocked and try again.
Če insulin še vedno ne pride ven, zamenjajte iglo, ker je morda zamašena in poskusite znova.
If still no insulin comes out, the needle may be blocked.
Če insulin še vedno ne pokaže, je igla morda zamašena.
If still no insulin comes out, the needle may be blocked.
Če insulin še vedno ne pride ven, je igla morda zamašena.
If still no insulin comes out, the needle may be blocked.
Če se insulin še vedno ne pokaže, je igla morda zamašena.
If stomatitis/mucositis has recovered to Grade ≤1, reduce by 1 dose level for 5-FU.
Če sta se stomatitis/mukozitis izboljšala do razreda ≤ 1, 5-FU zmanjšajte za 1 odmerno raven.